Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,786 public trials 652 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma

NCT03226392

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Andalusia, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 142 locations
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)

NCT03437278

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Rosario, Santa Fe Province, Argentina
  • Novartis Investigative Site Bahía Blanca, Argentina
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Brussels, Belgium
View all 20 locations
View Trial Details
Completed

Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma

NCT03215758

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Flagstaff, Arizona, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Long Beach, California, United States
View all 110 locations
View Trial Details
Completed

Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients

NCT03369704

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • Novartis Investigative Site Chiba, Japan
  • Novartis Investigative Site Ichikawa, Chiba, Japan
  • Novartis Investigative Site Kashiwa, Chiba, Japan
  • Novartis Investigative Site Matsudo, Chiba, Japan
View all 22 locations
View Trial Details

Related conditions